NIH abandons convalescent plasma trial in mild COVIDAnother trial of convalescent plasma in people with COVID-19 has missed the mark, this time in mild to Share XNIH abandons convalescent plasma trial in mild COVIDhttps://pharmaphorum.com/news/nih-abandons-convalescent-plasma-trial-in-mild-covid/
Convalescent plasma misses the mark in phase 2 trialHopes that antibody-laden plasma taken from recovered COVID-19 patients could lessen the severity of the disease in others Share XConvalescent plasma misses the mark in phase 2 trialhttps://pharmaphorum.com/news/convalescent-plasma-misses-the-mark-in-phase-2-trial/
Industry group says FDA botched COVID-19 convalescent plasma guidanceAlready under fire for what some view as a premature authorisation of convalescent plasma for COVID-19, the FDA Share XIndustry group says FDA botched COVID-19 convalescent plasma guidancehttps://pharmaphorum.com/news/industry-group-says-fda-botched-covid-19-convalescent-plasma-guidance/
COVID plasma treatment gets emergency license from FDA after Trump criticismThe FDA has allowed a blood plasma treatment for COVID-19 to be administered under an Emergency Use license Share XCOVID plasma treatment gets emergency license from FDA after Trump criticismhttps://pharmaphorum.com/news/covid-plasma-treatment-gets-emergency-license-from-fda-after-trump-criticism/
